Indolent B-Cell Non-Hodgkin Lymphoma — Trials

Indolent B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

617 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 172
Recruiting: 85
Ph III recruiting: 4
Growth YoY: +34.6%
Industry share: 22%
Top sponsor: City of Hope Medical Center
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (109)

clinicaltrialsPublishedShowing 101–103 of 103 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06228963	Orelabrutinib in the Treatment of HP-positive Gastric MALT Lymphoma	recruiting	Phase 2	160	Fudan UniversityOTHER	1	Feb 23, 2024	clinicaltrials
NCT05846750	Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Marginal Zone Lymphoma	recruiting	Phase 2	59	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	1	Jul 19, 2023	clinicaltrials